BioWorld MedTech

April 16, 2012

View Archived Issues

Clarification

Med-Tech Notes: CTS restarts Thailand EMS operations

Deals roundup: Shire acquires Pervasis Therapeutics for $200M

HIT roundup: Medtronic Foundation launches online save-a-life simulator

Product Briefs

MDD's Neurology Extra

Medtronic initiates landmark drug-eluting balloon study

Patients suffering from peripheral artery disease (PAD) in the superficial femoral artery and/or proximal popliteal artery traditionally have not had very good treatment options. Read More

Survey shows many unprepared for Sunshine Act implications

Report from Europe: Abiomed receives CE mark for Impella cVAD

FDA advisory committee: Panel urges class II, design controls for blood irradiators

Financings roundup: Inogen secures $20M equity funds for continued growth

MDD's Fun Facts

Agreements/contracts: GE Healthcare collaborates with Clino for R&D in AD

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...